Umoja Biopharma
Seattle, WA
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer. The company's treatment approach retools a patient’s immune system in vivo to direct potent anti-cancer immune cells to a patient’s tumor, augmenting the body’s natural mechanisms for fighting cancer.
umoja-biopharma.comCompany Details
Founded
- 2019
Employees
- Between 50 - 200 employees
Raised
- $363,000,000
Headquarters Location
- Seattle, WA
Public
- No
Acquired
- No
CEO
Andrew Scharenberg
Founders
- Michael JensenPhil LowRyan CrismanAndrew Scharenberg
Company Collections
These are collections Umoja Biopharma is a part of. Click on the collection name to view similar companies.
Umoja Biopharma's Industries
Umoja Biopharma's Investors
Current Job Listings
Listing 0 of 21 job openings
Umoja Biopharma Headquarters Location
1920 Terry Ave, Seattle, WA 98101
Total Amount Raised: $363,000,000
Umoja Biopharma's Investors
Umoja Biopharma Funding Rounds
Series C
$100,000,000
Series C Investors
DCVC BioDouble Point VenturesCormorant Asset ManagementMPM CapitalQiming Venture Partners USACaaS Capital ManagementRTW InvestmentsMyeloma Investment FundAlexandria Venture InvestmentsK2 HealthVenturesARK Investment ManagementSoftBank Vision FundEmerson CollectiveSeries B
$210,000,000
Series B Investors
Cormorant Asset ManagementSoftBank Vision FundCaaS Capital ManagementTemasekPresight CapitalRTW InvestmentsSVB LeerinkSeries A
$53,000,000
Series A Investors
MPM CapitalQiming Venture Partners USADCVC Bio
Funding info provided by Diffbot.
Umoja Biopharma Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Umoja Biopharma.